Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases
Globally, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) are the leading causes of the noncommunicable disease burden. Overlapping symptoms such as breathing difficulty and fatigue, with a lack of awareness about COPD among physicians, are key reasons for under-diagnosis an...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2021-01-01
|
| Series: | Tuberculosis and Respiratory Diseases |
| Subjects: | |
| Online Access: | http://www.e-trd.org/upload/pdf/trd-2020-0088.pdf |
| _version_ | 1818930670771109888 |
|---|---|
| author | Kartik Deshmukh Arjun Khanna |
| author_facet | Kartik Deshmukh Arjun Khanna |
| author_sort | Kartik Deshmukh |
| collection | DOAJ |
| description | Globally, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) are the leading causes of the noncommunicable disease burden. Overlapping symptoms such as breathing difficulty and fatigue, with a lack of awareness about COPD among physicians, are key reasons for under-diagnosis and resulting sub-optimal care relative to COPD. Much has been published in the past on the pathogenesis and implications of cardiovascular comorbidities in COPD. However, a comprehensive review of the prevalence and impact of COPD management in commonly encountered cardiac diseases is lacking. The purpose of this study was to summarize the current knowledge regarding the prevalence of COPD in heart failure, ischemic heart disease, and atrial fibrillation. We also discuss the real-life clinical presentation and practical implications of managing COPD in cardiac diseases. We searched PubMed, Scopus, EMBASE, and Google Scholar for studies published 1981–May 2020 reporting the prevalence of COPD in the three specified cardiac diseases. COPD has high prevalence in heart failure, atrial fibrillation, and ischemic heart disease. Despite this, COPD remains under-diagnosed and under-managed in the majority of patients with cardiac diseases. The clinical implications of the diagnosis of COPD in cardiac disease includes the recognition of hyperinflation (a treatable trait), implementation of acute exacerbations of COPD (AECOPD) prevention strategies, and reducing the risk of overuse of diuretics. The pharmacological agents for the management of COPD have shown a beneficial effect on cardiac functions and mortality. The appropriate management of COPD improves the cardiovascular outcomes by reducing hyperinflation and preventing AECOPD, thus reducing the risk of mortality, improving exercise tolerance, and quality of life. |
| first_indexed | 2024-12-20T04:04:24Z |
| format | Article |
| id | doaj.art-2e688a728c814b038311146093ea8af6 |
| institution | Directory Open Access Journal |
| issn | 1738-3536 2005-6184 |
| language | English |
| last_indexed | 2024-12-20T04:04:24Z |
| publishDate | 2021-01-01 |
| publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
| record_format | Article |
| series | Tuberculosis and Respiratory Diseases |
| spelling | doaj.art-2e688a728c814b038311146093ea8af62022-12-21T19:54:05ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842021-01-01841354510.4046/trd.2020.00883276Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular DiseasesKartik Deshmukh0Arjun Khanna1 Fuqua School of Business, Duke University, Durham, NC, USA Department of Pulmonary Medicine, Yashoda Hospital, Delhi, IndiaGlobally, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) are the leading causes of the noncommunicable disease burden. Overlapping symptoms such as breathing difficulty and fatigue, with a lack of awareness about COPD among physicians, are key reasons for under-diagnosis and resulting sub-optimal care relative to COPD. Much has been published in the past on the pathogenesis and implications of cardiovascular comorbidities in COPD. However, a comprehensive review of the prevalence and impact of COPD management in commonly encountered cardiac diseases is lacking. The purpose of this study was to summarize the current knowledge regarding the prevalence of COPD in heart failure, ischemic heart disease, and atrial fibrillation. We also discuss the real-life clinical presentation and practical implications of managing COPD in cardiac diseases. We searched PubMed, Scopus, EMBASE, and Google Scholar for studies published 1981–May 2020 reporting the prevalence of COPD in the three specified cardiac diseases. COPD has high prevalence in heart failure, atrial fibrillation, and ischemic heart disease. Despite this, COPD remains under-diagnosed and under-managed in the majority of patients with cardiac diseases. The clinical implications of the diagnosis of COPD in cardiac disease includes the recognition of hyperinflation (a treatable trait), implementation of acute exacerbations of COPD (AECOPD) prevention strategies, and reducing the risk of overuse of diuretics. The pharmacological agents for the management of COPD have shown a beneficial effect on cardiac functions and mortality. The appropriate management of COPD improves the cardiovascular outcomes by reducing hyperinflation and preventing AECOPD, thus reducing the risk of mortality, improving exercise tolerance, and quality of life.http://www.e-trd.org/upload/pdf/trd-2020-0088.pdfchronic obstructive pulmonary diseaseheart failureatrial fibrillationischemic heart diseasehyperinflationcardiovascular diseasesspirometrycopd-cvd |
| spellingShingle | Kartik Deshmukh Arjun Khanna Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases Tuberculosis and Respiratory Diseases chronic obstructive pulmonary disease heart failure atrial fibrillation ischemic heart disease hyperinflation cardiovascular diseases spirometry copd-cvd |
| title | Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases |
| title_full | Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases |
| title_fullStr | Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases |
| title_full_unstemmed | Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases |
| title_short | Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases |
| title_sort | implications of managing chronic obstructive pulmonary disease in cardiovascular diseases |
| topic | chronic obstructive pulmonary disease heart failure atrial fibrillation ischemic heart disease hyperinflation cardiovascular diseases spirometry copd-cvd |
| url | http://www.e-trd.org/upload/pdf/trd-2020-0088.pdf |
| work_keys_str_mv | AT kartikdeshmukh implicationsofmanagingchronicobstructivepulmonarydiseaseincardiovasculardiseases AT arjunkhanna implicationsofmanagingchronicobstructivepulmonarydiseaseincardiovasculardiseases |